We uncovered TACC3-KAT2A as an emerging regulatory axis caused by alternative splicing in HCC and propose FOXM1-driven TACC3 inhibition to synergistically disrupt mitotic fidelity and transcriptional regulation, potentially offering new therapeutic avenues for HCC with reduced toxicity to the normal liver.
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhao et al. (Tue,) studied this question.
synapsesocial.com/papers/69a75a6ec6e9836116a2039f — DOI: https://doi.org/10.3350/cmh.2025.1370
Li Na Zhao
University of Copenhagen
Jesper B. Andersen
University of Copenhagen
Clinical and Molecular Hepatology
University of Copenhagen
Building similarity graph...
Analyzing shared references across papers
Loading...